Inventor · disambiguated record
Klaus-Peter Kuenkele
Also filed as: KUENKELE KLAUS-PETER
20 granted patents·18 pending applications·153 citations·filing 2003–2025
94Inventor score
Top patents by PatentIndex Score
38 records- 0195US7462639B2Aminopyrazole derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Dec 9, 2008·46 cites·17 claims
- 0292US7572897B2Antibodies against insulin-like growth factor I receptor and uses thereofHOFFMANN LA ROCHE·Filed 2007·Granted Aug 11, 2009·19 cites·6 claims
- 0391US10611825B2Monovalent antigen binding proteinsHOFFMANN LA ROCHE·Filed 2017·Granted Apr 7, 2020·6 cites·8 claims
- 0491US9982036B2Dual FC antigen binding proteinsBOSSENMAIER BIRGIT·Filed 2012·Granted May 29, 2018·12 cites·3 claims
- 0589US11952418B2Biparatopic polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Apr 9, 2024·2 cites·3 claims
- 0686US7098241B2Thiophene hydroxamic acid derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 29, 2006·27 cites·34 claims
- 0785US7846724B2Method for selecting CHO cell for production of glycosylated antibodiesHOFFMANN LA ROCHE·Filed 2007·Granted Dec 7, 2010·9 cites·1 claims
- 0883US11033636B2Polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jun 15, 2021·2 cites·9 claims
- 0982US10597449B2Biparatopic polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 24, 2020·4 cites·13 claims
- 1082US7378503B2Antibodies against insulin-like growth factor 1 receptor and uses thereofHOFFMANN LA ROCHE·Filed 2004·Granted May 27, 2008·13 cites·10 claims
- 1180US10858438B2TRAILR2 CDH17 binding molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2017·Granted Dec 8, 2020·3 cites·42 claims
- 1276US7579157B2Antibody selection method against IGF-IRHOFFMANN LA ROCHE·Filed 2004·Granted Aug 25, 2009·7 cites·1 claims
- 1372US8703919B2Glycosylated antibodiesHANSEN SILKE·Filed 2011·Granted Apr 22, 2014·3 cites·1 claims
- 1471US2025345448A1Polypeptides antagonizing wnt signaling in tumor cellsABLYNX NV·Filed 2025·Application pending·0 cites
- 1568US12285493B2Polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 29, 2025·0 cites·8 claims
- 1662US10793621B2Nucleic acid encoding dual Fc antigen binding proteinsHOFFMANN LA ROCHE·Filed 2018·Granted Oct 6, 2020·0 cites·5 claims
- 1762US9724425B2Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2014·Granted Aug 8, 2017·0 cites·6 claims
- 1862US2009275126A1Antibodies against insulin-like growth factor i receptor and uses thereofGRAUS YVO·Filed 2009·Application pending·0 cites
- 1961US11673958B2Glycosylated antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Jun 13, 2023·0 cites·18 claims
- 2061US2025163157A1Bispecific antibodies against cd277 and a tumor-antigenBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2161US2024052065A1Binding molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2260US11851495B2TRAILR2 CDH17 binding molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2020·Granted Dec 26, 2023·0 cites·36 claims
- 2359US2010081796A1Bispecific anti-egfr/anti-igf-1r antibodiesBRINKMANN ULRICH·Filed 2009·Application pending·0 cites
- 2458US2024150480A1Binding molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2557US12275798B2Tri-specific binding moleculesBOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 15, 2025·0 cites·17 claims
- 2656US2013217623A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2754US2008226635A1Antibodies against insulin-like growth factor I receptor and uses thereofKOLL HANS·Filed 2007·Application pending·0 cites
- 2853US2012322732A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2012·Application pending·0 cites
- 2953US2006154865A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2005·Application pending·0 cites
- 3051US7285569B2Tricycles, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Oct 23, 2007·0 cites·11 claims
- 3149US2012237507A1Monovalent Antigen Binding ProteinsBOSSENMAIER BIRGIT·Filed 2012·Application pending·0 cites
- 3248US2011009317A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2010·Application pending·0 cites
- 3346US2010322927A1Glycosylated antibodiesHANSEN SILKE·Filed 2010·Application pending·0 cites
- 3445US2012149879A1Bispecific anti-egfr/anti-igf-1r antibodiesBRINKMANN ULRICH·Filed 2011·Application pending·0 cites
- 3544US2010323373A1Method for the assessment of the inhibitory activity of antibodies against insulin-like growth factor i receptorEVERS STEFAN·Filed 2008·Application pending·0 cites
- 3644US2012076778A1Antibodies Against Insulin-Like Growth Factor I Receptor and Uses ThereofKOLL HANS·Filed 2011·Application pending·0 cites
- 3738US2008014203A1Antibodies against insulin-like growth factor I receptor and uses thereofHANSEN SILKE·Filed 2007·Application pending·0 cites
- 3838US2006142247A1Tricyclic heterocyclesGEORGES GUY·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus-Peter Kuenkele files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →